@article{24621,
  keywords = {Borderline lepromatous leprosy, Hepatitis C, Treatment, Brazil},
  author = {Santos M and Franco EDS and Ferreira PLC and Braga WSM},
  title = {Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin.},
  abstract = {Hepatitis C is an inflammatory disease of the liver caused by a single-stranded RNA virus belonging to the Hepacivirus genus in the Flaviviridae family, called the hepatitis C virus. After initial infection, 70% to 85% of the patients develop chronic hepatitis C with hepatic fibrosis. In addition to specific liver changes, various extrahepatic manifestations have been associated with the hepatitis C virus infection or with medications used to treat the condition. We report the case of a patient with chronic hepatitis C who presented with the signs and symptoms of borderline tuberculoid leprosy and type 1 reaction four months after the start of treatment with a pegylated interferon/ribavirin combination.},
  year = {2013},
  journal = {Anais brasileiros de dermatologia},
  volume = {88},
  pages = {109-12},
  month = {2013 Nov-Dec},
  issn = {1806-4841},
  url = {http://www.scielo.br/pdf/abd/v88n6s1/0365-0596-abd-88-06-s1-0109.pdf},
  doi = {10.1590/abd1806-4841.20131986},
  language = {eng},
}